SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jardine K.)
 

Sökning: WFRF:(Jardine K.) > European perspectiv...

European perspective on human polyomavirus infection, replication and disease in solid organ transplantation

Hirsch, H. H. (författare)
Babel, N. (författare)
Comoli, P. (författare)
visa fler...
Friman, Vanda, 1952 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
Ginevri, F. (författare)
Jardine, A. (författare)
Lautenschlager, I. (författare)
Legendre, C. (författare)
Midtvedt, K. (författare)
Munoz, P. (författare)
Randhawa, P. (författare)
Rinaldo, C. H. (författare)
Wieszek, A. (författare)
visa färre...
 (creator_code:org_t)
Elsevier BV, 2014
2014
Engelska.
Ingår i: Clinical Microbiology and Infection. - : Elsevier BV. - 1198-743X. ; 20:suppl 7, s. 74-88
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Human polyomaviruses (HPyVs) are a growing challenge in immunocompromised patients in view of the increasing number of now 12 HPyV species and their diverse disease potential. Currently, histological evidence of disease is available for BKPyV causing nephropathy and haemorrhagic cystitis, JCPyV causing progressive multifocal leukoencephalopathy and occasionally nephropathy, MCPyV causing Merkel cell carcinoma and TSPyV causing trichodysplasia spinulosa, the last two being proliferative skin diseases. Here, the current role of HPyV in solid organ transplantation (SOT) was reviewed and recommendations regarding screening, monitoring and intervention were made. Pre-transplant screening of SOT donor or recipient for serostatus or active replication is currently not recommended for any HPyV. Post-transplant, however, regular clinical search for skin lesions, including those associated with MCPyV or TSPyV, is recommended in all SOT recipients. Also, regular screening for BKPyV replication (e.g. by plasma viral load) is recommended in kidney transplant recipients. For SOT patients with probable or proven HPyV disease, reducing immunosuppression should be considered to permit regaining of immune control. Antivirals would be desirable for treating proven HPyV disease, but are solely considered as adjunct local treatment of trichodysplasia spinulosa, whereas surgical resection and chemotherapy are key in Merkel cell carcinoma. Overall, the quality of the clinical evidence and the strength of most recommendations are presently limited, but are expected to improve in the coming years.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Merkel cell carcinoma
nephropathy
polyoma
progressive multifocal leukoencephalopathy
PyVAN
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
BK VIRUS NEPHROPATHY
MERKEL
CELL-CARCINOMA
LARGE T-ANTIGEN
RENAL-ALLOGRAFT RECIPIENTS
PEDIATRIC
KIDNEY RECIPIENTS
PROSPECTIVE SINGLE-CENTER
JC VIRUS
CLINICAL-IMPLICATIONS
LUNG TRANSPLANTATION
Infectious Diseases
Microbiology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy